Jiva Pharma CEO Om Prakash Goel Honored by Marquis Who's Who for Six Decades of Drug Discovery Innovation
核心洞察
Dr. Om Prakash Goel, founder and CEO of Jiva Pharma (搜索), has been selected for inclusion in Marquis Who's Who for his six decades of contributions to pharmaceutical R&D.
His key achievements include developing the manufacturing process for Lopid (gemfibrozil) and inventing a pure crystalline form of the ACE inhibitor Quinapril, recognized in the Merck Index.
Jiva Pharma (搜索) plans to file two new Investigational New Drug (IND) applications within the next two years, targeting novel chemical entity development.
Dr. Om Prakash Goel, PhD, a process chemistry pioneer whose innovations enabled the clinical development and market introduction of landmark cardiovascular therapies, has been selected for inclusion in Marquis Who's Who. The recognition, announced from Ann Arbor, Michigan, highlights a career spanning six decades of drug discovery, chemical development, and pharmaceutical entrepreneurship.
Dr. Goel earned his BSc (Honors) from the University of Delhi in 1962 before completing both a Master's degree and PhD in Organic Chemistry at the Carnegie Institute of Technology — now Carnegie Mellon University — under the mentorship of Professor Robert B. Carlin. This training launched a career that would bridge academic rigor with industrial-scale pharmaceutical manufacturing.
Pioneering Process Chemistry at Parke-Davis
Through Professor Carlin's referral, Dr. Goel joined the Process Chemistry group at Parke-Davis & Co. (搜索) in Detroit, where he rapidly distinguished himself and ultimately rose to lead Process Chemistry at the company's Ann Arbor Laboratories. There, he directed a team of more than 30 chemists in the development and scale-up of new drug entities for preclinical and clinical study.
Among his most significant achievements is the development of the manufacturing process for Lopid (gemfibrozil), a landmark therapy for lowering triglycerides. He also invented a pure crystalline form of the ACE inhibitor Quinapril — a breakthrough formally recognized in the Merck Index. These innovations proved instrumental in enabling successful clinical development and the timely market introduction of medicines that have benefited countless patients worldwide.
Building Jiva Pharma (搜索) and a Pipeline of Novel Candidates
Following his retirement from Warner-Lambert/Pfizer (搜索), Dr. Goel served as head of Process Chemistry at Ricerca Biosciences (搜索) from 2004 to 2006. In 2007, he founded Jiva Pharma (搜索) in Ann Arbor, Michigan, where he serves as Chief Executive Officer. Under his leadership, the company has grown into a hub of pharmaceutical innovation, with Dr. Goel personally credited with securing 24 independent patents.
The company anticipates filing two new Investigational New Drug (IND) applications within the next two years, further cementing its role at the forefront of novel chemical entity development. Jiva Pharma (搜索)'s pipeline includes several promising programs: sublingual formulations for depression treatment, over-the-counter analgesics for topical relief, patented liquid laxative and zinc acetate formulations for the treatment of Wilson's disease (搜索), and a formulation shown to reverse graying hair.
Dr. Goel also intends to expand the company's health supplements division as part of a broader strategy to grow Jiva Pharma (搜索)'s domestic and international footprint.
A Legacy of Scientific Rigor and Mentorship
Dr. Goel maintains active membership in the American Chemical Society and stays engaged with the field through regular reading of C&E News and the Wall Street Journal — a discipline he credits with bringing both deep scientific insight and financial acumen to Jiva Pharma (搜索)'s R&D strategy.
Beyond the laboratory, Dr. Goel leads a disciplined life, maintaining physical vitality through weightlifting and gym training three times weekly. He is the proud father of three accomplished children — a daughter with a Doctorate of Pharmacy from the University of Michigan, and a daughter and son who both hold Harvard Business School degrees — as well as a devoted grandfather to seven grandchildren.
A pioneering scientist, entrepreneur, and mentor, Dr. Goel continues to exemplify a combination of intellectual achievement, entrepreneurial vision, and deeply held personal values — a legacy defined by innovation and unwavering dedication to advancing human health.